期刊文献+

肾移植受者巨细胞病毒隐性感染的筛查方法及应用 被引量:8

Method of Screening Cytomegalovirus Recessive Infection in Renal Transplant Recipients and Its Application
下载PDF
导出
摘要 目的探讨肾移植受者巨细胞病毒(cytomegalovirus,CMV)隐性感染的筛查方法,为临床早期发现CMV活动性感染提供诊断依据。方法收集笔者医院2009年10~12月期间门诊随访233例肾移植受者外周静脉血标本450份,分别采用实时荧光定量PCR(Real-time PCR)、巢式PCR(nPCR)以及酶联免疫吸附(ELISA)法对标本进行检测,同时采用ELISA法检测他克莫司(Tac)浓度。结果 233例肾移植受者CMV-IgG均为阳性,CMV-IgM则均为阴性;Real-time PCR技术检测CMV-DNA阳性85例(36.48%),以低拷贝数为主。nPCR技术检测CMV-DNA阳性10例(4.29%),两种技术检测总阳性率存在显著性差异(P<0.05);随着Tac药物浓度升高,CMV-DNA阳性率呈增高趋势,药物高浓度组CMV-DNA阳性率高于低浓度组(P<0.05)。结论 Real-time PCR是筛查肾移植受者CMV隐性感染较为理想的方法,尤其在受者药物浓度偏高时更具有临床应用价值。 Objective To discuss the method of screening cytomegalovirus recessive infection in renal transplant recipients,provi- ding a reference basis for early detection of cytomegalovirus active infection. Methods Totally 450 samples from 233 patients from 2009 October to December in our transplant center were detected for cytomegalovirus by real - time PCR, nPCR and ELISA,detected for tacroli- mus concentration by ELISA at the same time. Results Among the 233 cases of renal transplant recipients,all of CMV - IgG were detec- ted positive,and CMV -IgM negative,in which 36.45% of the recipients were positive to real -time PCR and 4.29% were positive to nPCR. The former had a higher sensitivity than the latter( P 〈 0. 05 ). The contents of positive CMV - DNA were mainly low. CMV - DNA was positive trends to be higher. With the Tac drug concentration increasing, the posiative rate of CMV - DNA in drug high concentrations group were higher than low concentration group. Conclusion Real - time PCR is a more ideal method for screening CMV recessive infec- tion in renal transplant recipients, especially it has more clinical application value in the recipients when they have more high drug concen- tration.
出处 《医学研究杂志》 2012年第9期55-57,共3页 Journal of Medical Research
基金 浙江省医药卫生科学研究基金资助项目(2006B102)
关键词 巨细胞病毒 筛查 实时荧光定量聚合酶链反应 肾移植 Cytomegalovirus Screening Real- time quantitative polymerase chain reaction Renal transplantation
  • 相关文献

参考文献7

  • 1Pancholi P, Wu F, Della - Latta P. Rapid detection of cytomegalovirus infection in transplant patients [ J]. Expert Rev Mol Diagn, 2004,4 (2) :231 -242.
  • 2Sagedal S,Hartmann A, Rollay H. The impact of early cytomegalovirus infection and isease in renal transplant recipients[ J ]. Clin Microbiol Infect,2005,11 (7) :518 -530.
  • 3Boucher A, Lord H, Collette S, et al. Cytomegalovirus infection in kidney transplant recipients: evolution of approach through three eras. [ J ]. Transplant Proe ,2006 Dee ;38 (10) :3506 - 3508.
  • 4罗光华,叶青,高锦声.定量PCR检测巨细胞病毒在肾移植中的应用[J].国外医学(临床生物化学与检验学分册),2001,22(1):34-35. 被引量:3
  • 5Garrigue I, Boucher S, Couzi L, et al. Whole blood real - time quantitative PCR for cytomegalovirus infection follow - up in transplant recipients[J]. J Clin Virol,2006,36(1) :72 -75.
  • 6Caliendo AM,George KS, Kao SY,et al. Comparison of quantitative cy- tomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype AMPLICOR CMV MONITOR test in transplant recipients[J]. J Clin Microbiol,2000,38(6) :2122 -2127.
  • 7Lautenschlager I. CMV infection, diagnosis and antiviral strategies after liver transolantation[ J]. Transol lnt, 2009,22 ( 11 ) : 1031 - 1040.

二级参考文献10

  • 1Winston DJ.Prevention of cytomegalovirus disease in transplant recipients[].The Lancet.1995
  • 2Patel R,Paya CV.Infections in solid-organ transplant recipients[].Clinical Microbiology Reviews.1997
  • 3Schnitzler MA,Woodward RS,Brennan DC,et al.The effects of cytomegalovirus serology on graft and recipient survival in cadaveric renal transplantation: implications for organ allocation[].American Journal of Kidney Diseases.1997
  • 4Patel R,Snydman DR,Rubin RH,et al.Cytomegalovirus prophylaxis in solid organ transplant recipients[].Transplantation.1996
  • 5Farrugia E,Schwab TR.Management and prevention of cytomegalovirus infection after renal trasplantation[].Mayo Clinic Proceedings.1992
  • 6Schafer P,Tenschert W,Cremaschi L,et al.Utility of major leukocyte subpopulations for monitoring secondary cytomegalovirus infections in renal-allograft recipients by PCR[].Journal of Clinical Microbiology.1998
  • 7Stratta RJ.Clinical patterns and treatment of cytomegalovirus infection after solid-orgen transplantation[].Transplantation Proceedings.1993
  • 8Nevins TE,Dunn DL.Use of ganciclovir for cytomegalovirus infection[].Journal of the American Society of Nephrology.1992
  • 9Roberts TC,Brennan DC,Buller RS,et al.Quantitative polymerase chain reaction to predict occurrence of symptomatic cytomegalovirus infection and assess response to ganciclovir therapy in renal transplant recipients[].The Journal of Infectious Diseases.1998
  • 10Tong CY,Cuevas L,Williams H,et al.Use of laboratory assays to predict cytomegalovirus disease in renal transplant recipients[].Journal of Clinical Microbiology.1998

共引文献2

同被引文献49

  • 1张丽娜.巨细胞病毒感染与儿童特发性血小板减少性紫癜的关系[J].江苏医药,2005,31(2):140-140. 被引量:13
  • 2陈艳波,王华,张孔.肾移植术后巨细胞病毒肺炎合并急性呼吸窘迫综合征临床及预后分析[J].中国实用内科杂志,2007,27(5):350-352. 被引量:6
  • 3周永昌.超声医学[M].北京:科学技术文献出版社,2002.1208-1210.
  • 4Zhang X,Huang YP,Gao HN,et al. Quantification of cytomegalovirus glycoprotein Bn DNA in hematopoietic stem cell transplant recipients by real-time PCR [J]. PLoS One, 2012,7(12): e51224.
  • 5Rha B, Redden D, Benfield M,et al. Correlation and clinical utility of pp65 antigenemia and quantitative polymerase chain reaction assays for detection of cytomegalovims in pediatric renal transplant patients [J]. Pediatr Transplant, 2012,16(6):627-637.
  • 6Cariani E,Pollara CP,Valloncini B,et al. Relationship between ppp65 antigenemia levels and real-time quanti- tative DNA PCR for Human Cytomegalovirus (HCMV) management in immunocompromised patients [J]. BMC Infect Dis,2007,7:138.
  • 7Capria S, Gentile G, Capobianchi A, et al. Prospective cy- tomegalovirus monitoring during first-line chemotherapy in patients with acute myeloid leukemia[J]. J Med Virol,2010, 82(7):1201-1207.
  • 8Solano C ,Munoz I,Gutierrez A,et al. Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigene- mia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stein cell transplantation [J]. J Clin Microbiol, 2001 , 39 (11): 3938-3941.
  • 9Landreneau K, Lee K, Landreneau MD. Quality of Life in patients undergoing hemodialysis and renal transplantation-a meta-analytie review[J]. N Engl J Med,2010,37( 1 ) :37-44.
  • 10D. F. Florescu,A. C. Kalil,F. Qiu,C. M. Schmidt,U. Sandkovsky.What Is the Impact of Hypogammaglobulinemia on the Rate of Infections and Survival in Solid Organ Transplantation? A Meta‐Analysis[J].American Journal of Transplantation.2013(10)

引证文献8

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部